C-Section pain relief: could a wound pump replace spinal morphine?

NCT ID NCT01211431

Terminated Symptom relief Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a continuous infusion of numbing and anti-inflammatory drugs directly into the C-section wound can control pain as well as a standard spinal injection of morphine. The study enrolls women having a planned C-section with a single, healthy pregnancy. Researchers will compare pain scores, side effects, and the risk of long-term scar pain between the two approaches.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ropivacaine and diclofenac (wound infusion) vs. morphine (spinal injection)
What this could lead to: If the wound infusion works as well as morphine, it could offer a safer, more convenient option for post-cesarean pain relief with fewer side effects.
What could go wrong: This is a small, single-center Phase 4 trial, so results may not apply to all patients. The experimental treatment might not match morphine's effectiveness or could have its own side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CESAREAN SECTION

More trials for these conditions

Other studies related to the condition(s) this trial covers.